BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6090368)

  • 1. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
    Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
    Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
    Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
    Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
    Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report.
    Shin KH; Urtasun RC; Fulton D; Geggie PH; Tanasichuk H; Thomas H; Muller PJ; Curry B; Mielke B; Johnson E
    Cancer; 1985 Aug; 56(4):758-60. PubMed ID: 3893680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
    Urtasun R; Feldstein ML; Partington J; Tanasichuk H; Miller JD; Russell DB; Agboola O; Mielke B
    Br J Cancer; 1982 Jul; 46(1):101-8. PubMed ID: 6285947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
    Panis X; Nguyen TD; Froissart D; Demange L
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
    Abratt RP; Barnes DR; Hammond JA; Sarembok LA; Tucker RD; Williams AM
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast neutrons and misonidazole for malignant astrocytomas.
    Kurup PD; Pajak TF; Hendrickson FR; Nelson JS; Mansell J; Cohen L; Awschalom M; Rosenberg I; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):679-86. PubMed ID: 2984151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
    Sealy R; Cridland S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.
    Fazekas J; Pajak TF; Wasserman T; Marcial V; Davis L; Kramer S; Rotman M; Stetz J
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1155-60. PubMed ID: 3301758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer. A randomized double-blind trial.
    Jakobsson M; Taskinen PJ; Kylmämaa T
    Strahlenther Onkol; 1987 Feb; 163(2):90-3. PubMed ID: 3031840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas.
    Br J Radiol; 1983 Sep; 56(669):673-82. PubMed ID: 6309314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.